Gross-to-Net Accruals

Master Accurate and Automated Gross-to-Net Accrual Management 

Automated gross-to-net accruals empowers pharmaceutical finance teams to make informed, educated business decisions, driving better visibility and product profitability.

Manual GTN Business Challenges

Pharmaceutical finance and market access teams face four critical business challenges – inefficiency and rework, risky manual process, financial statement errors, audit points & compliance issues – as they try to accurately accrue for the vast number of rebates, discounts, chargebacks, admin fees, copay programs, and other sales-related adjustments and incentives.

The four business challenges of manual pharma/biotech gross-to-net accruals and accounting: inefficient and rework, risky manual processes, financial statement errors, audit points and compliance issues

IntegriChain’s Gross-to-net (GTN) software is an end-to-end revenue solution for your market access and finance departments. Offered as Software-as-a-Service (SaaS), Business Process-as-a-Service (BPaaS), and hybrid operating models, our deployment options are flexible, scalable, auditable, and customizable to your business needs. By automating GTN, you can improve margins, reduce costs, mitigate risk, and drive business decisions based on actionable analytics.

High-Performance Design and Capabilities

The functionality of GTN Accruals is configured for all standard line items with robust out-of-the-box accrual methodologies including:

  • Methodology library to calculate current month close accruals
  • Prior period true-up functionality
  • Inventory pipeline adjustments to accruals
  • Balance sheet roll-forward and reconciliations
  • Preconfigured reports and dashboards
High Performance Design Capabilities of GTN Accrual Software
Business Benefits of Automated Gross to Net Accruals

Business Benefits Realized

  • Quicker Close. Close books and forecasts in fewer days by reducing and eliminating manual data collection & calculations. 
  • Easier Audit. Built-in auditability, traceability, and scalability reduces audit prep time by up to 30%. 
  • More Secure Environment. Strong access, privacy, and security controls ensures a “single version of the truth” approach to data and calculations.  
  • More Accurate Accruals. Bottoms-up with transparency to details and consistency of models across businesses and brands.  
  • Deeper Insights and Decision Support. Advanced analytics and data visualization provide improved decision-making regarding brand-level profitability, price/volume analysis, and “what-if” scenario and price-change modeling. 
  • ‘Real-time’ Reporting. Partnership, brand, and product family-level reporting is available at your fingertips. 

Part of the Larger GTN Solution

IntegriChain’s GTN Accruals solution is part of our broader GTN solution that delivers on four distinct types of capabilities:

Gtn Accrual Box Diagram: 1) Automation & Digitalization 2) Implementation Blueprint 3) Data-Driven Insights 4) People & Process

Features of GTN Software:

  • Integrated Data Mart
  • Methodology Library
  • Automated Data Cleansing
  • Scalability & Auditability
  • Payer Mix and Returns Analog Benchmarks
  • Commercial Contracting and Government Regulation Expertise
  • GTN What-if Analytics
  • Sales/Demand/Inventory Harmonization
  • SOC Certified Processes and Controls
  • Project Accelerators
  • Customer and Auditor Training

Interested in learning more?

Automate Your GTN Processes


5 Pharma Gross-To-Net Questions You Should Be Asking

Whether manufacturers are entering new therapeutic categoriesexploring new indications for a current product, or looking to acquire a new product through acquisition, portfolio growth presents both opportunities and challenges.

Read the Blog


Why Modernize Your Gross-To-Net?
5 Benefits of Pharma Digital Transformation​

In the current pharmaceutical landscape, more than 80% of manufacturers still rely on manual processes to accrueforecast, and report their gross-to-net (GTN) deductions. However, in the era of big data and technological enhancements, manual processes cannot be relied on forever.

Read the Blog

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article